| 书目名称 | Congestive Heart Failure |
| 副标题 | Proceedings of the S |
| 编辑 | Joel Morganroth (Prof. of Med. and Pharm.),E. Neil |
| 视频video | |
| 丛书名称 | Developments in Cardiovascular Medicine |
| 图书封面 |  |
| 描述 | About 2. 5 million individuals have congestive heart fai lure in the United States with over 400,000 new cases expected annually. Congestive heart failure also is one of the commonest causes for hospital admissions accounting for over 5 million hospital days per year. Despite the early recognition of this condition and active medical research into both mechanisms and therapy, prognosis continues to remain dismal wi th less than a 50% expected five year survival. In the last decade we have seen many new medical and therapeutic options for patients with congestive heart failure which extend beyond the use of bed rest, sodium restriction, digitalis and diuretics. These include vasodilators of a variety of types including the angiotensin conventional enzyme (ACE) inhibitors. Also, many new inotropes are under active investigation both in oral and intravenous forms. In March of 1984 a survey of over 5000 physicians was performed under the auspices of the American Heart Association (reported in: JAOC 8:966, 1986). That survey showed that there was no universally accepted defini tion for congestive heart fai lure and that a wide spectrum of diagnostic cri teria for this common condi tion |
| 出版日期 | Conference proceedings 1987 |
| 关键词 | arrhythmia; drugs; electrophysiology; heart; heart failure; physiology; sudden cardiac death |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-1-4613-2077-7 |
| isbn_softcover | 978-1-4612-9232-6 |
| isbn_ebook | 978-1-4613-2077-7Series ISSN 0166-9842 |
| issn_series | 0166-9842 |
| copyright | Martinus Nijhoff Publishing, Boston 1987 |
发表于 2025-3-21 18:36:01
